Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions - Wikidata - awgldk - TriplyDB

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

http://www.wikidata.org/entity/Q36367890

about

Asthma severity and prevalence: an ongoing interaction between exposure, hygiene, and lifestyle T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity Monitoring Allergen Immunotherapy Effects by Microarray Allergen Immunotherapy: Past, Present, and Future Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future T Cell Epitope Peptide Therapy for Allergic Diseases Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy Recombinant allergens: the present and the future Food allergies: the basics Immunological mechanisms of allergen-specific immunotherapy Pathogenic CD4+ T cells in patients with asthma.Cockroach allergen Bla g 2: structure, function, and implications for allergic sensitization.The role of allergy in severe asthma.Epitope-specific T-cell responses and allergic phenotypes: implications for T-cell peptide therapy.Allergens and their role in the allergic immune response.Strategies to query and display allergy-derived epitope data from the immune epitope database.Immune responses to inhalant Mammalian allergens.MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.Depigmented-polymerised allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3.T cells in allergy and anergy.Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.Therapeutic strategies for allergic diseases.A new mechanism for immunologic initiation of asthma.Mechanisms of allergen-specific immunotherapy.Allergen immunotherapy: does it work and, if so, how and for how long?In vitro evolution of allergy vaccine candidates, with maintained structure, but reduced B cell and T cell activation capacity Mechanisms of interleukin-10-mediated immune suppression.Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?Inhibition of human T-cell responses by allergen peptides.Latex allergy: towards immunotherapy for health care workers.Allergen-specific CD8(+) T cells and atopic disease.Peptide immunotherapy for allergic disease.Drug development for asthma.Peptide-induced immune regulation by a promiscuous and immunodominant CD4T-cell epitope of Timothy grass pollen: a role of Cbl-b and Itch in regulation Mold allergens in respiratory allergy: from structure to therapy.New targets for allergic rhinitis--a disease of civilization.Genes of tolerance.Tregs and allergic disease Tolerizing allergic responses in the lung.

P2860

Q24794345-FB6EE262-2D62-4248-9756-EA1CACCF82AC Q24805470-3F7A4659-BCDF-4293-8904-4DBD7717FCDA Q26743503-5348F515-B60C-4EF6-A5D6-D1622A5BA729 Q26765974-D3B8472E-51CF-4F41-9E23-9DA6F36A1BF0 Q26768511-2569E909-4750-487E-9025-CD07931A53AE Q26771989-2D9E8271-DF6C-4C22-B1E0-CD0DBC166A72 Q26822702-8B31C912-C5D6-4DDB-9521-BB5FD7FB368A Q26852113-648A1FD2-358D-4513-9D49-DA58B2E6B231 Q26996701-192ACB62-6BAD-4188-B5BC-5DAF27ED8D43 Q27011839-3FC5525F-E43B-43E8-901B-615E1CA08B34 Q28265326-F2C927A3-F583-4909-8C66-2BF2F3E10D2B Q30252507-B1C28372-BFF0-4E45-8B61-7F264E70A8C3 Q30308608-A07E6D92-A87E-43CF-9F10-9C954A96D774 Q30419500-4152DC8C-5D6E-408E-A9F3-72763DCEA5CC Q30450873-188EA466-24C2-47BC-82F1-98E3DC57A300 Q30453700-EB1802FC-9BB2-4CFB-89FD-A36489424CB5 Q30578181-009B7EF5-F628-4746-93CF-B79B22021C23 Q33659111-EA138F31-CED4-424F-8F44-C8C876A278D5 Q33702755-AC0CD4B3-5B5F-4F2A-962F-74ED4491F15F Q33732171-DD3CC8CF-D5D8-48F4-85EE-CC111A56C1C6 Q33757858-19333BCA-E9A2-4304-ACE1-CF500B257FB2 Q33781091-BEC8D188-6CBA-4A95-A0C6-2B57D2E5087A Q33787614-46DFC854-E8AF-447C-B5C6-250F56933626 Q33820182-DAFC35CA-3D53-4F22-ADD4-7C01E48F18C1 Q33945896-6AD26C02-CA9E-4A7F-8D0E-D598DAB0E019 Q34004397-9C947674-C606-4960-8E28-281FAF4E820E Q34023674-10D077C9-A27B-4D18-A421-5E8E053EA281 Q34285968-A44E02BD-E399-431B-855F-44DDDC7737F7 Q34567725-F2464DBB-B382-4F8E-811D-996CBEFFC5BC Q34567734-62DBEF6C-DBBE-4ACA-BB76-BC3500F45B03 Q34626983-A77E2D96-EDAF-4A9B-8E7D-EFDCE17475AD Q34815169-7E4B284D-BFE9-4FA9-99A3-46AEFE47AE0D Q35164800-86EDE396-707C-4E83-9599-E1121F4998B9 Q35183997-72224E8C-DE3C-43CA-A0C7-3B5DA220E6D0 Q35203703-795D44E1-F836-4578-BAF0-C319DD2FE2B4 Q35420488-C843806A-066A-4BE2-B76E-EED64EF0AA7F Q35605442-039D8809-5F0E-431F-8EDB-0AE68C0AC4C8 Q35855013-F3E2FDA7-F582-44EE-B86F-AE339AC576E5 Q35951537-D7715793-8CEB-4098-A5FC-FD9D2CB2DD4E Q36054136-A604DA62-8B6A-49C7-B95E-07718FC0B666

P2860

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

http://www.wikidata.org/entity/Q36367890

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh

1999年學術文章

@zh-hant

name

Immunoglobulin E-independent m ...... duced late asthmatic reactions

@ast

Immunoglobulin E-independent m ...... duced late asthmatic reactions

@en

type

label

Immunoglobulin E-independent m ...... duced late asthmatic reactions

@ast

Immunoglobulin E-independent m ...... duced late asthmatic reactions

@en

prefLabel

Immunoglobulin E-independent m ...... duced late asthmatic reactions

@ast

Immunoglobulin E-independent m ...... duced late asthmatic reactions

@en

P1433

Q36367890-27BCF268-7101-460E-A162-2089368C3F8A

P1476

Q36367890-F134E14F-EA86-4E76-962D-D23BD4780EB6

P2093

Q36367890-000ECC03-F160-4FBD-BC15-58F33F2B4619

Q36367890-7C5803C2-F3D6-498B-9E63-B96AC1585223

Q36367890-7DB55DB1-A914-4A1A-81DF-34B62C5A51B7

P2860

Q36367890-07135DD4-4082-40EF-8910-7A83E9CEE12A

Q36367890-42E82FCB-3759-4115-90A8-6ACBCA329AF8

Q36367890-4996C4DD-1746-4E5B-AD8C-6D90D12222E9

Q36367890-4E0EFA89-0781-45AF-BA37-665D98C588A3

Q36367890-5686711E-D252-4163-9B9C-0C1722D67E21

Q36367890-5C50CCE3-535E-4F42-97F1-31F04D30028D

Q36367890-63504CA7-5595-4CF6-AFB7-1F0528C66000

Q36367890-9348642D-1AC8-46D9-A5A1-DA87EBF20867

Q36367890-9899FBC6-BB44-414B-8213-338742AD6187

Q36367890-98DCC1DC-DE23-434F-B883-10C602146D04

P304

Q36367890-A97D4A3D-6B38-4BB1-B000-2FD0CE887490

P31

Q36367890-5673FD7F-AE0B-4761-8F25-8E9E61EE4188

P356

Q36367890-7B0C01BB-3102-45BA-9EC2-F45325B70D73

P407

Q36367890-4A1DBAC8-518A-4661-AAFC-2346B5139977

P433

Q36367890-1721C750-99B8-47DB-89CC-668310B374C0

P478

Q36367890-86A4B12B-3D67-420A-B9D7-B328603D2933

P577

Q36367890-C9767D07-FD6E-4740-9C3B-BE50FDD6B288

P5875

Q36367890-259174A4-C755-41B7-9374-7A59F1A1B20D

P698

Q36367890-439F36B4-5C56-4176-A4FD-4C881C5D211C

P921

Q36367890-08B77D30-4A7F-43DB-85F0-9B2894C30969

P932

Q36367890-3D9C89F2-30DF-44CC-8647-8F6FEAFF6F6C

P356

JEM.189.12.1885

P1433

Journal of Experimental Medicine

P1476

Immunoglobulin E-independent m ...... duced late asthmatic reactions

@en

P2093

A B Kay

http://www.w3.org/2001/XMLSchema#string

B M Haselden

http://www.w3.org/2001/XMLSchema#string

M Larché

http://www.w3.org/2001/XMLSchema#string

P2860

Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

T cells and eosinophils in the pathogenesis of asthma.

Effect of cyclosporin A on the allergen-induced late asthmatic reaction.

Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats.

The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies

H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen

Enhanced detection of human IL-5 in biological fluids utilizing murine monoclonal antibodies which delineate distinct neutralizing epitopes.

Eosinophils: biology and role in disease.

P304

1885-1894

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.189.12.1885

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P577

1999-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12922297

http://www.w3.org/2001/XMLSchema#string

P698

10377184

http://www.w3.org/2001/XMLSchema#string

P921

P932

2192970

http://www.w3.org/2001/XMLSchema#string